Preview

Topical biotechnology

Advanced search

ОРИЕНТАЦИЯ ГАПТЕНА И СПЕЦИФИЧНОСТЬ ИММУНОАНАЛИЗА МАЛЫХ МОЛЕКУЛ

https://doi.org/10.20914/2304-4691-2020-3-48-52

About the Authors

М. Буркин
НИИВС им. И.И. Мечникова
Russian Federation


И. Гальвидис
НИИВС им. И.И. Мечникова
Russian Federation


References

1. Pfaller M.A., Krogstad D.J., Granich G.G., Murray P.R. Laboratory evaluation of five assay methods for vancomycin: Bioassay, high-pressure liquid chromatography, fluorescence polarization immunoassay, radioimmunoassay, and fluorescence immunoassay. J. Clin. Microbiol. 1984, 20, 311-316.

2. Burkin M.A.; Burkin A.A. Enzyme immunoassay for the determination of the glycopeptide antibiotic eremomycin. Appl. Biochem. Microbiol. 2009, 45, 210-214.

3. Corti A., Cavenaghi L., Giani E., Cassani G. A receptor-antibody sandwich assay for teicoplanin. Clin. Chem. 1987, 33, 1615-1618.

4. Hermanson G.T. Bioconjugate Techniques, 3d ed.; Elsevier: Amsterdam, 2013;p. 1140.

5. Galvidis I.A., Eremin S.A., Burkin M.A. Development of indirect competitive enzyme-linked immune assay of colistin for milk and egg analysis. Food Agric. Immunol. 2020, 31(1), 424-434.

6. Carraway K.L., Koshland D.E. Jr. Reaction of tyrosine residues in proteins with carbodiimide reagents. Biochim. Biophys. Acta 1968, 160, 272-274.

7. Galvidis I.A., Burkin K.M., Eremin S.A., Burkin M.A. Group-specific detection of 2-deoxystreptamine aminoglycosides in honey based on antibodies against ribostamycin. Anal. Methods 2019, 11, 4620-4628.

8. Galvidis I.A., Eremin S.A., Burkin M.A. Three for the price of one! Immunodetection of three amphenicols in foodstuffs using universal standard curve. Anal. Methods 2020, 12, 1728-1735.

9. Burkin M.A., Galvidis I.A. Simultaneous and differential determination of drugs and metabolites using the same antibody: Difloxacin and sarafloxacin case. Anal. Methods 2016, 8, 5843-5850.

10. Lamont, E.;Seaton, R.A.;Macpherson, M.;Semple, L.;Bell, E.;Thomson, A.H. Development of teicoplanin dosage guidelines for patients treated within an outpatient parenteral antibiotic therapy (OPAT) programme. J. Antimicrob. Chemother. 2009, 64, 181-187.


Review

For citations:


 ,   . Topical biotechnology. 2020;(3):48-52. (In Russ.) https://doi.org/10.20914/2304-4691-2020-3-48-52

Views: 29


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2304-4691 (Print)